Abstract
A 65-year-old woman presented with a 6-month history of abdominal pain and watery diarrhea. Type II enteropathy-associated T-cell lymphoma (EATL) was diagnosed based on the clinical presentation and pathological examination of the tumor. The patient received combination chemotherapy but did not achieve remission. Subsequently, high-dose therapy (HDT) and autologous stem cell transplantation (ASCT) were performed. After these therapies, she achieved complete remission, which has been sustained for 18 months. Although the role of HDT-ASCT for EATL is still controversial, the clinical course of this patient suggests that ASCT can improve the prognosis in some patients with EATL.
MeSH terms
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Combined Modality Therapy
-
Cyclophosphamide / administration & dosage
-
Doxorubicin / administration & dosage
-
Doxorubicin / analogs & derivatives
-
Enteropathy-Associated T-Cell Lymphoma / drug therapy*
-
Enteropathy-Associated T-Cell Lymphoma / therapy*
-
Female
-
Humans
-
Jejunal Neoplasms / drug therapy*
-
Jejunal Neoplasms / therapy*
-
Peripheral Blood Stem Cell Transplantation*
-
Prednisolone / administration & dosage
-
Remission Induction
-
Transplantation, Autologous
-
Vincristine / administration & dosage
Substances
-
Vincristine
-
Doxorubicin
-
Cyclophosphamide
-
Prednisolone